SCI Innovation Awards

In keeping with its core mission, the Stanford Cancer Institute has been dedicated to advancing cancer research through the SCI Innovation Awards program since 2013. The awards support projects focused on accelerating basic, translational, clinical, and population-based cancer research and projects focused on specific types of cancer, such as pancreatic, breast, gynecologic, and sarcoma cancers. We strongly encourage candidates of diverse backgrounds, women, and young investigators to apply.

AWARD CATEGORIES:

  • Stanford Cancer Institute Nodal Awards - $50,000
    The SCI offers a funding mechanism, which aims to catalyze the planning and execution of multi-PI grants from the National Cancer Institute, including R01s, P01s and SPOREs. The funds are intended to be used to obtain proof of concept data and support planning activities.   
  • Stanford Cancer Institute Cancer Innovation Award - $50,000
    The SCI offers awards to support projects focused on the acceleration of basic, translational, clinical and population-based cancer research and collaborations leading to multi PI peer-reviewed funding.
  • Stanford Cancer Institute Pancreatic Cancer Innovation Award - $50,000
    The SCI offers awards leading to a greater understanding of pancreatic cancer, with the ultimate goal of improving the prevention or treatment of pancreatic cancer.
  • SCI Women’s Cancer Center Innovation Award - $50,000
    With support from the fundraising efforts of Under One Umbrella, the SCI and the Stanford Women’s Cancer Center offer awards for research projects related to women’s cancers.
  • Shmunis Family Innovation Awards in Cancer Therapeutics - $50,000
    The SCI is pleased to offer these new awards focused on cancer drug development and cancer therapeutics.  We encourage proposals that are “high-risk, high-reward drug development projects” which enable researchers to develop and therapeutic modalities that could lead to early phase clinical trials and transformative new treatments for patients.
  • Behar Innovation Awards in Sarcoma Research - $50,000
    The SCI offers awards leading to a greater understanding of sarcoma, with the ultimate goal of improving the prevention or treatment of sarcoma.
  • *NEW*  Michael Toshio Cure for Cancer Catalyst Award - $100,000
    The SCI offers awards to support the development of investigator-initiated trials (IITs) that lead to transformative new treatments and interventions for patients. 

 

PROJECT PRIORITIES:

  • Bold and creative research projects
  • Research related to cancer health equity
  • Research related to leukemia, lymphoma, melanoma, sarcoma, breast, GI, pancreatic, liver, lung cancers
  • Multi-disciplinary collaboration, including collaborations involving Stanford faculty beyond the School of Medicine or inter-programmatic collaborations across the seven SCI research programs
  • Investigator-initiated clinical trial
  • Plans for submission of an external peer-reviewed (preferably NCI) application 

SUBMISSION DEADLINE:  May 23, 2024 

RFA Announced: March 15, 2024
Notification of Selection: August 2024
Funding Period: October 1, 2024 – September 30, 2025